Mr Arnold Reynaldi

Cromer D; Reynaldi A; Steain M; Triccas JA; Davenport MP; Khoury DS, 2022, 'Relating In Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial.', CLINICAL INFECTIOUS DISEASES, http://dx.doi.org/10.1093/cid/ciac075

Cromer D; Steain M; Reynaldi A; Schlub TE; Wheatley AK; Juno JA; Kent SJ; Triccas JA; Khoury DS; Davenport MP, 2022, 'Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis', The Lancet Microbe, vol. 3, pp. e52 - e61, http://dx.doi.org/10.1016/S2666-5247(21)00267-6

Kent SJ; Khoury DS; Reynaldi A; Juno JA; Wheatley AK; Stadler E; John Wherry E; Triccas J; Sasson SC; Cromer D; Davenport MP, 2022, 'Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?', Nature Reviews Immunology, http://dx.doi.org/10.1038/s41577-022-00716-1

Goel RR; Painter MM; Apostolidis SA; Mathew D; Meng W; Rosenfeld AM; Lundgreen KA; Reynaldi A; Khoury DS; Pattekar A; Gouma S; Kuri-Cervantes L; Hicks P; Dysinger S; Hicks A; Sharma H; Herring S; Korte S; Baxter AE; Oldridge DA; Giles JR; Weirick ME; McAllister CM; Awofolaju M; Tanenbaum N; Drapeau EM; Dougherty J; Long S; D’Andrea K; Hamilton JT; McLaughlin M; Williams JC; Adamski S; Kuthuru O; Frank I; Betts MR; Vella LA; Grifoni A; Weiskopf D; Sette A; Hensley SE; Davenport MP; Bates P; Luning Prak ET; Greenplate AR; John Wherry E, 2021, 'mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern', Science, vol. 374, pp. eabm0829, http://dx.doi.org/10.1126/science.abm0829

Wheatley AK; Juno JA; Wang JJ; Selva KJ; Reynaldi A; Tan HX; Lee WS; Wragg KM; Kelly HG; Esterbauer R; Davis SK; Kent HE; Mordant FL; Schlub TE; Gordon DL; Khoury DS; Subbarao K; Cromer D; Gordon TP; Chung AW; Davenport MP; Kent SJ, 2021, 'Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19', Nature Communications, vol. 12, pp. 1162, http://dx.doi.org/10.1038/s41467-021-21444-5

Lee WS; Reynaldi A; Amarasena T; Davenport MP; Parsons MS; Kent SJ, 2021, 'Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121', Frontiers in Immunology, vol. 12, http://dx.doi.org/10.3389/fimmu.2021.749891

Cromer D; Steain M; Reynaldi A; Schlub T; Wheatley A; Juno J; Kent S; Triccas J; Khoury D; Davenport M, 2021, 'SARS-CoV-2 variants: levels of neutralisation required for protective immunity', , http://dx.doi.org/10.1101/2021.08.11.21261876

Selva K; Davis S; Haycroft E; Lee WS; Lopez E; Reynaldi A; Davenport M; Kent H; Juno J; Chung A; Kent S, 2021, 'Tear antibodies to SARS-CoV-2: implications for transmission', , http://dx.doi.org/10.1101/2021.08.02.21261479

Khoury DS; Cromer D; Reynaldi A; Schlub TE; Wheatley AK; Juno JA; Subbarao K; Kent SJ; Triccas JA; Davenport MP, 2021, 'Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection', Nature Medicine, vol. 27, pp. 1205 - 1211, http://dx.doi.org/10.1038/s41591-021-01377-8

Cromer D; Reynaldi A; Steain M; Triccas J; Davenport M; Khoury D, 2021, 'Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial', , http://dx.doi.org/10.1101/2021.06.29.21259504

Lee WS; Selva KJ; Davis SK; Wines BD; Reynaldi A; Esterbauer R; Kelly HG; Haycroft ER; Tan HX; Juno JA; Wheatley AK; Hogarth PM; Cromer D; Davenport MP; Chung AW; Kent SJ, 2021, 'Decay of Fc-dependent antibody functions after mild to moderate COVID-19', Cell Reports Medicine, vol. 2, pp. 100296, http://dx.doi.org/10.1016/j.xcrm.2021.100296

Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP, 2021, 'Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection', Nature Reviews Immunology, vol. 21, pp. 395 - 404, http://dx.doi.org/10.1038/s41577-021-00550-x

Khoury D; Cromer D; Reynaldi A; Schlub T; Wheatley A; Juno J; Subbarao K; Kent S; Triccas J; Davenport M, 2021, 'What level of neutralising antibody protects from COVID-19?', , http://dx.doi.org/10.1101/2021.03.09.21252641

Margaretha H; Reynaldi A; Sofian F; Jap L; Saputra KVI, 2021, 'A Dynamical Model of Dengue Primary and Secondary Infections with an Application to Microinsurance', International Journal of Mathematics and Computer Science, vol. 16, pp. 1045 - 1062

Selva KJ; Davis SK; Haycroft ER; Lee WS; Lopez E; Reynaldi A; Davenport MP; Kent HE; Juno JA; Chung AW; Kent SJ, 2021, 'Tear antibodies to SARS-CoV-2: implications for transmission', Clinical and Translational Immunology, vol. 10, pp. e1354, http://dx.doi.org/10.1002/cti2.1354

Khoury DS; Wheatley AK; Ramuta MD; Reynaldi A; Cromer D; Subbarao K; O’Connor DH; Kent SJ; Davenport MP, 2020, 'Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models', Nature Reviews Immunology, vol. 20, pp. 727 - 738, http://dx.doi.org/10.1038/s41577-020-00471-1

Ju Y; Kelly HG; Dagley LF; Reynaldi A; Schlub TE; Spall SK; Bell CA; Cui J; Mitchell AJ; Lin Z; Wheatley AK; Thurecht KJ; Davenport MP; Webb AI; Caruso F; Kent SJ, 2020, 'Person-specific biomolecular coronas modulate nanoparticle interactions with immune cells in human blood', ACS Nano, vol. 14, pp. 15723 - 15737, http://dx.doi.org/10.1021/acsnano.0c06679

Juno JA; Tan HX; Lee WS; Reynaldi A; Kelly HG; Wragg K; Esterbauer R; Kent HE; Batten CJ; Mordant FL; Gherardin NA; Pymm P; Dietrich MH; Scott NE; Tham WH; Godfrey DI; Subbarao K; Davenport MP; Kent SJ; Wheatley AK, 2020, 'Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19', Nature Medicine, vol. 26, pp. 1428 - 1434, http://dx.doi.org/10.1038/s41591-020-0995-0

Vanderven HA; Barr I; Reynaldi A; Wheatley AK; Wines BD; Davenport MP; Hogarth PM; Kent SJ, 2020, 'Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults', Vaccine, vol. 38, pp. 2368 - 2377, http://dx.doi.org/10.1016/j.vaccine.2020.01.066

Reynaldi A; Dent AE; Schlub TE; Ogolla S; Rochford R; Davenport MP, 2019, 'Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants', Malaria Journal, vol. 18, pp. 19, http://dx.doi.org/10.1186/s12936-019-2657-6

Parsons MS; Lee WS; Kristensen AB; Amarasena T; Khoury G; Wheatley AK; Reynaldi A; Wines BD; Hogarth PM; Davenport MP; Kent SJ, 2019, 'Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques', Journal of Clinical Investigation, vol. 129, pp. 182 - 191, http://dx.doi.org/10.1172/JCI122466

Reynaldi A; Smith NL; Schlub TE; Tabilas C; Venturi V; Rudd BD; Davenport MP, 2019, 'Fate mapping reveals the age structure of the peripheral T cell compartment', Proceedings of the National Academy of Sciences of the United States of America, vol. 116, pp. 3974 - 3981, http://dx.doi.org/10.1073/pnas.1811634116

Deleage C; Immonen TT; Fennessey CM; Reynaldi A; Reid C; Newman L; Lipkey L; Schlub TE; Camus C; O'Brien S; Smedley J; Conway JM; Del Prete GQ; Davenport MP; Lifson JD; Estes JD; Keele BF, 2019, 'Defining early SIV replication and dissemination dynamics following vaginal transmission', Science Advances, vol. 5, pp. eaav7116, http://dx.doi.org/10.1126/sciadv.aav7116

Pino M; King C; Shim I; Wang H; Nguyen K; Samer S; Harper J; Lifson J; Reynaldi A; Deleage C; Padhan K; Cervasi B; Davenport MP; Petrovas C; Lederman MM; Paiardini M, 2019, 'Fingolimod treatment at ART initiation delays SIV rebound after ART interruption', Journal of Virus Eradication, vol. 5, pp. 3 - 3, http://dx.doi.org/10.1016/s2055-6640(20)31078-5

Stern J; Roche M; Solomon A; Dantanarayana A; Reynaldi A; Davenport M; Deeks SG; Hartogenesis W; Hecht FM; Cockerham L; Lewin SR, 2019, 'Cell-associated HIV RNA and the ratio of HIV RNA to DNA have circadian cycles in HIV-positive individuals on antiretoviral therapy', Journal of Virus Eradication, vol. 5, pp. 10 - 10, http://dx.doi.org/10.1016/s2055-6640(20)31037-2

Smith NL; Patel RK; Reynaldi A; Grenier JK; Wang J; Watson NB; Nzingha K; Yee Mon KJ; Peng SA; Grimson A; Davenport MP; Rudd BD, 2018, 'Developmental Origin Governs CD8⁺ T Cell Fate Decisions during Infection', Cell, vol. 174, pp. 117 - 130.e14, http://dx.doi.org/10.1016/j.cell.2018.05.029

Lloyd SB; Niven KP; Kiefel BR; Montefiori DC; Reynaldi A; Davenport MP; Kent SJ; Winnall WR, 2017, 'Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV', Human Vaccines and Immunotherapeutics, vol. 13, pp. 2726 - 2737, http://dx.doi.org/10.1080/21645515.2017.1368935

Lee WS; Kristensen AB; Rasmussen TA; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Mark Hogarth P; Reynaldi A; Davenport MP; Emery S; Amin J; Cooper DA; Kan VL; Fox J; Gruell H; Parsons MS; Kent SJ, 2017, 'Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption', Journal of Virology, vol. 91, http://dx.doi.org/10.1128/JVI.00603-17

Vanderven HA; Liu L; Ana-Sosa-Batiz F; Nguyen THO; Wan Y; Wines B; Mark Hogarth P; Tilmanis D; Reynaldi A; Parsons MS; Hurt AC; Davenport MP; Kotsimbos T; Cheng AC; Kedzierska K; Zhang X; Xu J; Kent SJ, 2017, 'Fc functional antibodies in humans with severe H7N9 and seasonal influenza', Journal of Clinical Investigation, vol. 2, http://dx.doi.org/10.1172/jci.insight.92750

Fennessey CM; Pinkevych M; Immonen TT; Reynaldi A; Venturi V; Nadella P; Reid C; Newman L; Lipkey L; Oswald K; Bosche WJ; Trivett MT; Ott DE; Estes JD; Del Prete GQ; Lifson JD; Davenport MP; Keele BF, 2017, 'Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy', PLoS Pathogens, vol. 13, http://dx.doi.org/10.1371/journal.ppat.1006359

Lee WS; Kristensen AB; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Hogarth PM; Reynaldi A; Davenport M; Emery S; Amin J; Cooper DA; Kan V; Fox J; Grüll H; Parsons MS; Kent SJ; Rasmussen TA, 2017, '13 HIV-1-specific ADCC following anti-latency therapy and analytical treatment interruption', Journal of Virus Eradication, vol. 3, pp. 10 - 10, http://dx.doi.org/10.1016/s2055-6640(20)30718-4

Reynaldi A; Schlub TE; Piriou E; Ogolla S; Sumba OP; Moormann AM; Rochford R; Davenport MP, 2016, 'Modeling of EBV Infection and Antibody Responses in Kenyan Infants with Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection', Journal of Infectious Diseases, vol. 214, pp. 1390 - 1398, http://dx.doi.org/10.1093/infdis/jiw396

Reynaldi A; Smith NL; Schlub TE; Venturi V; Rudd BD; Davenport MP, 2016, 'Modeling the dynamics of neonatal CD8⁺ T-cell responses', Immunology and Cell Biology, vol. 94, pp. 838 - 848, http://dx.doi.org/10.1038/icb.2016.47

Younes SA; Freeman ML; Mudd JC; Shive CL; Reynaldi A; Panigrahi S; Estes JD; Deleage C; Lucero C; Anderson J; Schacker TW; Davenport MP; McCune JM; Hunt PW; Lee SA; Serrano-Villar S; Debernardo RL; Jacobson JM; Canaday DH; Sekaly RP; Rodriguez B; Sieg SF; Lederman MM, 2016, 'IL-15 promotes activation and expansion of CD8⁺ T cells in HIV-1 infection', Journal of Clinical Investigation, vol. 126, pp. 2745 - 2756, http://dx.doi.org/10.1172/JCI85996

Ortiz AM; Carnathan DG; Yu J; Sheehan KM; Kim P; Reynaldi A; Vanderford TH; Klatt NR; Brenchley JM; Davenport MP; Silvestri G, 2016, 'Analysis of the in vivo turnover of CD4+ T-cell subsets in chronically SIV-infected sooty mangabeys', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0156352

Reynaldi A; Schlub TE; Chelimo K; Sumba PO; Piriou E; Ogolla S; Moormann AM; Rochford R; Davenport MP, 2016, 'Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children', Journal of Infectious Diseases, vol. 213, pp. 985 - 991, http://dx.doi.org/10.1093/infdis/jiv525

2016, 'Oral abstracts of the 21st International AIDS Conference 18-22 July 2016, Durban, South Africa.', J Int AIDS Soc, vol. 19, pp. 21264, http://dx.doi.org/10.7448/IAS.19.6.21264

Pinkevych M; Reynaldi A; Fennessey C; Reid C; Nadella P; Lipkey L; Newman L; Ayala V; Jain S; Del Prete G; Estes J; Ott D; Lifson J; Ohlen C; Keele B; Davenport M, 2016, 'OA2-1 Frequent and ‘burst-like’ reactivation from latency in SIVmac239M infected macaques', Journal of Virus Eradication, vol. 2, pp. 2 - 2, http://dx.doi.org/10.1016/s2055-6640(20)31008-6

Juno J; Wragg K; Lee WS; Amarasena T; Reynaldi A; Koutsakos M; Konstandopoulos P; Field K; Esterbauer R; Tan H-X; Kent H; Davenport M; Wheatley A; Kent S, 'Tracking the kinetics and phenotype of spike epitope-specific CD4 T cell immunity in the context of SARS-CoV-2 infection and vaccination', , http://dx.doi.org/10.21203/rs.3.rs-957030/v1

Cromer D; Steain M; Reynaldi A; Schlub TE; Sasson SC; Kent SJ; Khoury DS; Davenport MP, Neutralising antibodies predict protection from severe COVID-19, http://dx.doi.org/10.1101/2022.06.09.22275942